Why is Oxygenta Pharmaceutical Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 35.68% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 94.89%, its profits have risen by 97.6%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Oxygenta Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Oxygenta Pharma
94.89%
1.91
49.69%
SENSEX
0.45%
0.03
14.48%
Quality key factors
Factor
Value
Sales Growth (5y)
35.68%
EBIT Growth (5y)
-17.32%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
0.76
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
-42.44%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
-14.33
EV to EBIT
-27.49
EV to EBITDA
-34.87
EV to Capital Employed
9.34
EV to Sales
4.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.41%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Movement
16What is working for the Company
NET SALES(Q)
Highest at Rs 33.21 cr
-6What is not working for the Company
PBDIT(Q)
Lowest at Rs -4.35 cr.
PBT LESS OI(Q)
Lowest at Rs -5.45 cr.
PAT(Q)
At Rs -3.93 cr has Fallen at -5.4%
Loading Valuation Snapshot...
Here's what is working for Oxygenta Pharma
Net Sales - Quarterly
At Rs 33.21 cr has Grown at 262.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
Highest at Rs 33.21 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Oxygenta Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -5.45 cr has Fallen at -54.39%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -4.35 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -5.45 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -3.93 cr has Fallen at -5.4%
Year on Year (YoY)MOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)